PTGS2 and breast cancer: In light of the findings from our mouse experiments, we conducted an analysis of BC patients’ tumors, considering the expression of cyclooxygenase 2 (COX-2), VD3 metabolizing enzymes, VDR expression, as well as 25(OH)D3 plasma levels.